OPRK1 and inflammation: KOR agonists reduced LPS-induced iNOS, COX-2, TNF-α, and IL-1β over-expression in alveolar macrophages within 2 hours after LPS activation, and such effects can be partially blocked by KOR antagonist, suggesting KOR might play critical role in modulating the acute phase of pulmonary inflammation via macrophages.